Click Vivian, Drum Melissa, Reader Al, Nusstein John, Beck Mike
Private Practice of Endodontics, Honolulu, Hawaii.
Division of Endodontics, The Ohio State University, Columbus, Ohio.
J Endod. 2015 Jan;41(1):16-21. doi: 10.1016/j.joen.2014.09.010. Epub 2014 Nov 6.
Few studies have evaluated the effectiveness of the Gow-Gates and Vazirani-Akinosi techniques in patients presenting with symptomatic irreversible pulpitis. Therefore, the purpose of this prospective, randomized study was to evaluate the anesthetic efficacy of the Gow-Gates and Vazirani-Akinosi techniques using 3.6 mL 2% lidocaine with 1:100,000 epinephrine in mandibular posterior teeth in patients presenting with symptomatic irreversible pulpitis.
One hundred twenty-five emergency patients diagnosed with symptomatic irreversible pulpitis randomly received either a Gow-Gates or Vazirani-Akinosi injection using 3.6 mL 2% lidocaine with 1:100,000 epinephrine to block the inferior alveolar nerve before endodontic access. Subjective lip numbness was recorded. Pulpal anesthetic success of the injection was defined as no pain or mild pain upon endodontic access and instrumentation as measured on a visual analog scale.
Subjective lip numbness was obtained 92% of the time with the Gow-Gates technique and 63% of the time with the Vazirani-Akinosi technique. The difference was statistically significant (P = .0001). For the patients achieving lip numbness, successful pulpal anesthesia was obtained 35% of the time with the Gow-Gates technique and 16% of the time with the Vazirani-Akinosi technique. The difference was statistically significant (P = .0381).
We concluded that for patients who achieved lip numbness neither the Gow-Gates technique nor the Vazirani-Akinosi technique provided adequate pulpal anesthesia for mandibular posterior teeth in patients presenting with symptomatic irreversible pulpitis. Both injections would require supplemental anesthesia.
很少有研究评估Gow-Gates技术和Vazirani-Akinosi技术在有症状的不可逆性牙髓炎患者中的有效性。因此,这项前瞻性随机研究的目的是评估在有症状的不可逆性牙髓炎患者的下颌后牙中,使用3.6毫升2%利多卡因加1:100,000肾上腺素的Gow-Gates技术和Vazirani-Akinosi技术的麻醉效果。
125名被诊断为有症状的不可逆性牙髓炎的急诊患者在进行牙髓治疗前,随机接受使用3.6毫升2%利多卡因加1:100,000肾上腺素的Gow-Gates注射或Vazirani-Akinosi注射,以阻滞下牙槽神经。记录主观唇部麻木情况。注射的牙髓麻醉成功定义为在牙髓治疗和器械操作时,根据视觉模拟量表测量无疼痛或轻度疼痛。
Gow-Gates技术有92%的时间获得主观唇部麻木,Vazirani-Akinosi技术有63%的时间获得主观唇部麻木。差异具有统计学意义(P = .0001)。对于实现唇部麻木的患者,Gow-Gates技术有35%的时间获得成功的牙髓麻醉,Vazirani-Akinosi技术有16%的时间获得成功的牙髓麻醉。差异具有统计学意义(P = .0381)。
我们得出结论,对于实现唇部麻木的患者,Gow-Gates技术和Vazirani-Akinosi技术均不能为有症状的不可逆性牙髓炎患者下颌后牙提供足够的牙髓麻醉。两种注射均需要补充麻醉。